Search company, investor...


Founded Year



Series B | Alive

Total Raised


Last Raised

$18.4M | 14 yrs ago

About ProtAffin

ProtAffin is a pre-clinical biotechnology company developing protein-based products countering inflammation. Its biologics targets the heparin-like glycan structures that drive inflammatory processes.

Headquarters Location

Impulszentrum Graz-West Reininghausstrasse 13a


Missing: ProtAffin's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: ProtAffin's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing ProtAffin

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

ProtAffin is included in 1 Expert Collection, including Biopharma Tech.


Biopharma Tech

15,535 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

ProtAffin Patents

ProtAffin has filed 1 patent.

patents chart

Application Date

Grant Date


Related Topics




Cytokines, Clusters of differentiation, Chemokine receptors, Olfactory receptors


Application Date


Grant Date



Related Topics

Cytokines, Clusters of differentiation, Chemokine receptors, Olfactory receptors



ProtAffin Frequently Asked Questions (FAQ)

  • When was ProtAffin founded?

    ProtAffin was founded in 2005.

  • What is ProtAffin's latest funding round?

    ProtAffin's latest funding round is Series B.

  • How much did ProtAffin raise?

    ProtAffin raised a total of $23.7M.

  • Who are the investors of ProtAffin?

    Investors of ProtAffin include Aescap Venture, Entrepreneurs Fund, Z-cube, Atlas Venture and SR One.

  • Who are ProtAffin's competitors?

    Competitors of ProtAffin include Bone Biologics, Celtaxsys, Potentia Pharmaceuticals, Merrimack Pharmaceuticals, Alpha Biologics and 12 more.

Compare ProtAffin to Competitors

Cambridge Biostability

Cambridge Biostability Limited (CBL) is a UK Biotechnology Company based on the Cambridge Science Park.

Green Biologics Logo
Green Biologics

Green Biologics is an industrial biotechnology company focused on the production of renewable n-butanol and other C4 chemicals from various renewable feedstocks, including sugar (cane, molasses, beets), starch (corn) and cellulosic biomass (corn residues, sugar cane bagasse, forest materials and grasses). The company works with feedstock partners to deliver capital efficient production models, and works with downstream partners to deliver high quality, competitively priced products. Green Biologics' focus is on the global renewable chemicals and biofuels markets.

Bio-Link Logo

Bio-Link is a National Advanced Technological Education (ATE) Center for Biotechnology that originated in late 1998 with a grant from the National Science Foundation. The ATE program was created to improve and expand educational programs that prepare skilled technicians to work in the high-tech fields that drive the U.S. economy. Bio-Link enhances and expands biotechnology education programs by providing professional development for instructors, by improving curriculum, by making use of technologies and by creating a system that promotes the sharing of information. The Bio-Link National Center is at City College of San Francisco with office space at the University of California San Francisco. Regional Bio-Link Centers across the country are located in Seattle, WA; San Diego, CA; San Francisco, CA; Austin, TX; Madison, WI; Graham, NC; and Portsmouth, NH. The regional centers develop relations with local industry and educational institutions including community colleges, baccalaureate institutions, and high schools. In addition, each regional center spearheads a different element of the program. Bio-Link is supporting a cadre of well-trained instructors and is increasing the number and quality of biotechnology programs for students. Bio-Link aiming to bring a range of underrepresented students to biotechnology who have the knowledge and skills essential to the field as well as the ability to continue with more advanced education in math, science and engineering. At a press conference, on October 15th, 1998, at City College of San Francisco (CCSF), Chancellor Philip R. Day, Jr. stated, "Bio-Link represents a opportunity for community colleges to take a lead in technical training and retraining for the skilled biotechnology workforce of the twenty-first century."nnDr. Elaine Johnson, Director of the National Center and faculty member of CCSF remarked, "In making this award, NSF recognizes both the importance of creating a high performance technical workforce for a competitive global economy and the critical role community and technical colleges play in the education of technicians."

Logical Therapeutics

Logical Therapeutics is an early stage biotechnology company, developing medicines to treat diseases that are associated with poorly controlled or excessive inflammation.


CellXplore is a new, biotechnology company engaged in the development of biomarker-based in vitro diagnostic assays for cancer, initially focusing on breast cancer. Although mammography is an effective screening test for early detection, there is a need for a simple, reliable and sensitive biomarker-based in vitro assay that can be used to stage and characterize breast cancer.nThe company was formed to commercialize groundbreaking discoveries demonstrating up-regulation of the ubiquitin-proteasome pathway in cancerous breast tissue, providing the capability for the noninvasive detection of breast cancer and the ability to monitor the efficacy of chemotherapeutic interventions.nCellXplore's platform technology is not restricted to breast cancer in vitro diagnostics alone, nor is it restricted to cancer diagnostics alone. Beyond cancer, CellXplore is already investigating whether similar blood sample biomarkers can be identified for the early diagnosis of several major debilitating diseases such as muscle wasting, Alzheimer's disease, Parkinson's disease and inflammatory diseases.

Halsa Pharmaceuticals

Halsa Pharmaceuticals is a biotechnology company developing therapeutics for the treatment of obesity, diabetes, cachexia and other metabolic diseases.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.